JPH0443690B2 - - Google Patents

Info

Publication number
JPH0443690B2
JPH0443690B2 JP58242891A JP24289183A JPH0443690B2 JP H0443690 B2 JPH0443690 B2 JP H0443690B2 JP 58242891 A JP58242891 A JP 58242891A JP 24289183 A JP24289183 A JP 24289183A JP H0443690 B2 JPH0443690 B2 JP H0443690B2
Authority
JP
Japan
Prior art keywords
hollow fiber
fiber membrane
water
medical
spinning
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58242891A
Other languages
Japanese (ja)
Other versions
JPS60132566A (en
Inventor
Koji Kimura
Tsutomu Kawamura
Masaru Kaneizumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyobo Co Ltd
Original Assignee
Toyobo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyobo Co Ltd filed Critical Toyobo Co Ltd
Priority to JP24289183A priority Critical patent/JPS60132566A/en
Publication of JPS60132566A publication Critical patent/JPS60132566A/en
Publication of JPH0443690B2 publication Critical patent/JPH0443690B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は医療用中空糸膜の製造方法に関する。 高分子重合体から成る多孔質中空糸膜は選択透
過性能を有し、その性質を生かして色々な用途に
使われている。その中空糸膜の製造に際して原料
組成、中空糸膜形成の方法、後処理の方法等を使
用目的に応じた条件下で行なうことにより、多種
多様な中空糸膜が供されている。中でも医療分野
への進出は目ざましいものがあり、時に人工透析
用の中空糸膜はその適用を受けるべき腎疾患者が
多いことも相まつて増産の一途をたどつている。
一方、医療分野を対象とする中空糸膜は製造から
ユーザーに供されるまで、安全衛生面において十
分な配慮がなされなければならない。 高分子化合物を、溶剤に溶解させて紡糸原液と
し、この紡糸原液を紡糸ノズルから芯液と共に押
し出し、凝固させた後洗浄して溶剤を除去するよ
うな中空糸膜製造方法においてその洗浄剤として
特殊な薬剤を使つたり、不純物を含有する水を使
う場合があるが、これらではそれらの薬剤や不純
物が中空糸膜に残留し医療用中空糸膜としてはは
なはだ不適当である。また菌を含有する水を使う
ことも、中空糸膜に菌を付着させる結果になり好
ましくない。菌は通常いたるところに存在し、ち
よつとした油断で容易に中空糸膜製造工程に混入
するし、菌の平均世代時間はその種類によつても
異なるが数十分から数時間であり、このことは一
度混入した菌は容易に増殖することを意味する。
医療器具の製造にあたつては清浄な室いわゆるク
リーンルームで行なわれるのが通常であるがそれ
でもなお楽観はできない。 通常医療用中空糸はモジユールに作成され、ユ
ーザーに供されるまでの間に滅菌の工程を経て安
全性が高められている。モジユール作成までにそ
の中空糸が菌を含有していたならば滅菌の工程で
生菌をなくすることはできるものの、例えばバイ
ロジエン(発熱性物質)等は含有しているおそれ
がある。 本発明者等は菌の付着にしていない医療用中空
糸膜を得るための手段について鋭意検討の結果本
発明を見い出すに至つた。 即ち、本発明は高分子化合物を溶剤に溶解させ
て紡糸原液としこの紡糸原液を紡糸ノズルから芯
液と共に押し出し凝固させた後洗浄して紡糸原液
の溶剤を除去する医療用中空糸膜製造方法におい
て、洗浄の工程を多段に分割し、その洗浄水とし
て無菌水を使用し、中空糸膜の走行する方向と逆
方向に流下させることを特徴とするものである。 ここで本発明に用いる無菌水とは日本薬局方の
無菌試験法のメンブランフイルター法により試験
し合格した水である。 本発明において使用する高分子化合物とは、格
別限定を設けるものでなくセルロースジアセテー
ト、セルローストリアセテート等のセルロースエ
ステル;銅アンモニア法セルロース;ポリアクリ
ロニトリル;ポリメチルメチクリレート;ポリエ
チレン;酢酸ビニル共重合体;ポリビニルアルコ
ール;ポリプロピレン等を挙げることができる。 これらの高分子化合物は適当な溶剤に溶解し紡
糸原液に作製する。そしてこの紡糸原液を環状紡
糸孔より紡出させ必要に応じて空気中を走行せし
めた後凝固させる。凝固が完了した中空糸はこの
後洗浄され、前記溶剤は除去され医療用中空糸膜
が製造される。本発明において重要な点はかかる
洗浄に際し洗浄水として無菌水を用いることにあ
る。かかる手段を採用することにより保有菌数の
全くない中空糸膜が製造できた。かかる洗浄工程
は一段の浴、あるいは多段に分割された浴で行な
われるが好ましくは洗浄を効率が高められる多段
分割(数段〜十数段)の方法である。この多段分
割ではそれぞれの独立した浴に新鮮な無菌水を流
下させ中空糸膜を処理する。また万一混入した生
菌に対してその増殖を未然に防ぐために洗浄工程
に紫外線殺菌灯を設けることが好ましい。この様
な洗浄水は中空糸膜の走行する方向と逆方向に流
下させる。 この様に医療様中空糸膜の製造にあたり、洗浄
水として無菌水を用いることにより無菌状態の安
全衛生面に充分配慮のなされた中空糸膜がつくら
れこれは医療分野へ大きく貢献できるものであ
る。 以下本発明の実施例を記載するが本発明はこれ
ら実施例によつて何等限定をうけるものでない。 実施例1〜3及び比較例1〜2 セルロースアセテート30重量部、ジメチルホル
ムアミド49重量部、ポリエチレングリコール200
を21重量部を85℃で2時間撹拌して溶解し、紡糸
原液を作製した。この紡糸原液を85℃で2時間静
置脱泡した。環状オリフイスノズルを用いて紡糸
を行なつた。一方芯液として流動パラフインを供
給した。環状オリフイスを出た中空状の原液を15
cm空気中を走行させ、その後凝固浴に導き凝固さ
せその後水洗、洗浄した。この洗浄には下記の3
通りでその都度無菌水を調整し中空糸膜の進行方
向と逆方向に流下せしめ実施した。この後ボビン
状に巻き上げた。 実施例 1 洗浄工程のカナルを3セクシヨンに分割し各々
のセクシヨンの最後部に無菌水を導入。 実施例 2 多段式カナルの3段各々のカナルを独立させ各
カナルの最後部に無菌水を導入。 実施例 3 実施例2に同様であるが、更に各カナルに紫外
線殺菌灯照射を実施。 なお、比較として無菌水の代わりにイオン交換
水を使用した例も検討した。 比較例 1 実施例1に同様であるが無菌水の代わりにイオ
ン交換水を使用。 比較例 2 実施例2に同様であるが無菌水の代わりにイオ
ン交換水を使用。 上記実施例、比較例の経時的に行なつた結果を
第1表にまとめた。
The present invention relates to a method for producing a medical hollow fiber membrane. Porous hollow fiber membranes made of high molecular weight polymers have selective permeation performance, and are used in a variety of applications by taking advantage of this property. A wide variety of hollow fiber membranes are available by changing the raw material composition, method of forming the hollow fiber membrane, post-treatment method, etc. under conditions depending on the purpose of use. Among these, there has been a remarkable expansion into the medical field, and the production of hollow fiber membranes for artificial dialysis is steadily increasing, partly because there are many patients with renal diseases who need them.
On the other hand, hollow fiber membranes intended for the medical field must be given sufficient consideration in terms of health and safety from manufacture to delivery to users. Specially used as a cleaning agent in hollow fiber membrane manufacturing methods, in which a polymer compound is dissolved in a solvent to form a spinning dope, this spinning dope is extruded together with a core solution from a spinning nozzle, coagulated, and then washed to remove the solvent. In some cases, chemicals or water containing impurities are used, but in these cases, the chemicals and impurities remain in the hollow fiber membrane, making it extremely unsuitable for use as a medical hollow fiber membrane. Furthermore, the use of water containing bacteria is also undesirable as it results in bacteria adhering to the hollow fiber membrane. Bacteria are usually present everywhere and can easily be introduced into the hollow fiber membrane manufacturing process with the slightest carelessness, and the average generation time of bacteria varies depending on the type, but ranges from several tens of minutes to several hours. This means that once contaminated, bacteria can easily multiply.
The manufacturing of medical devices is normally carried out in clean rooms, but even so, we cannot be optimistic. Usually, medical hollow fibers are made into modules and undergo a sterilization process to increase safety before being delivered to the user. If the hollow fibers contain bacteria before the module is made, viable bacteria can be eliminated in the sterilization process, but there is a risk that they may still contain, for example, virogien (a pyrogenic substance). The inventors of the present invention have discovered the present invention as a result of intensive studies on means for obtaining medical hollow fiber membranes that are free from adhesion of bacteria. That is, the present invention provides a method for manufacturing hollow fiber membranes for medical use, in which a polymer compound is dissolved in a solvent to form a spinning dope, and this spinning dope is extruded from a spinning nozzle together with a core solution, coagulated, and then washed to remove the solvent from the spinning dope. This method is characterized in that the washing process is divided into multiple stages, and sterile water is used as the washing water, and the washing water is made to flow in a direction opposite to the direction in which the hollow fiber membrane runs. The sterile water used in the present invention is water that has been tested and passed by the membrane filter method of the sterility test method of the Japanese Pharmacopoeia. The polymer compounds used in the present invention are not particularly limited, and include cellulose esters such as cellulose diacetate and cellulose triacetate; cuprammonium cellulose; polyacrylonitrile; polymethyl methacrylate; polyethylene; and vinyl acetate copolymer. ; polyvinyl alcohol; polypropylene and the like. These polymer compounds are dissolved in a suitable solvent to prepare a spinning stock solution. Then, this spinning dope is spun out from an annular spinning hole, passed through the air as required, and then solidified. The coagulated hollow fiber is then washed to remove the solvent and produce a medical hollow fiber membrane. An important point in the present invention is that sterile water is used as the washing water during such washing. By employing such a method, a hollow fiber membrane containing no bacteria could be produced. This washing step may be carried out in a single bath or in a bath divided into multiple stages, but preferably a multi-stage divided method (several stages to more than ten stages) is preferred because it increases the cleaning efficiency. In this multistage division, fresh sterile water flows down into each independent bath to treat the hollow fiber membranes. In addition, it is preferable to provide an ultraviolet sterilizing lamp in the cleaning process in order to prevent the proliferation of viable bacteria that may have been contaminated. Such washing water is caused to flow down in the direction opposite to the direction in which the hollow fiber membrane runs. In this way, when producing medical hollow fiber membranes, by using sterile water as the washing water, hollow fiber membranes with sufficient consideration given to the safety and hygiene aspects of sterile conditions can be created, which can greatly contribute to the medical field. . Examples of the present invention will be described below, but the present invention is not limited in any way by these Examples. Examples 1 to 3 and Comparative Examples 1 to 2 30 parts by weight of cellulose acetate, 49 parts by weight of dimethylformamide, 200 parts by weight of polyethylene glycol
A spinning stock solution was prepared by stirring and dissolving 21 parts by weight at 85° C. for 2 hours. This spinning stock solution was left standing at 85° C. for 2 hours to defoam. Spinning was carried out using an annular orifice nozzle. On the other hand, liquid paraffin was supplied as a core liquid. The hollow stock solution exiting the annular orifice is
cm in air, then introduced into a coagulation bath to coagulate, and then rinsed with water. For this cleaning, follow the 3 steps below.
Sterile water was adjusted each time on the street and flowed down in the opposite direction to the direction of travel of the hollow fiber membrane. After that, it was wound into a bobbin shape. Example 1 The canal for the cleaning process was divided into three sections and sterile water was introduced at the end of each section. Example 2 The canals of each of the three stages of the multi-stage canal were made independent, and sterile water was introduced into the rearmost part of each canal. Example 3 Same as Example 2, but each canal was further irradiated with an ultraviolet germicidal lamp. For comparison, we also considered an example in which ion-exchanged water was used instead of sterile water. Comparative Example 1 Same as Example 1, but using ion exchange water instead of sterile water. Comparative Example 2 Same as Example 2, but using ion exchange water instead of sterile water. The results of the above Examples and Comparative Examples over time are summarized in Table 1.

【表】【table】

【表】【table】

【表】 以上の結果より医療用中空糸膜の製造にあた
り、洗浄水として無菌水を用いれば保有状態の全
くない医療用途に適切な中空糸膜が作製されるこ
とがわかる。
[Table] From the above results, it can be seen that when producing medical hollow fiber membranes, if sterile water is used as the washing water, hollow fiber membranes suitable for medical use without any retention state can be produced.

Claims (1)

【特許請求の範囲】[Claims] 1 高分子化合物を溶剤に溶解させて紡糸原液と
し、この紡糸原液を紡糸ノズルから芯液と共に押
出し凝固させた後洗浄して紡糸原液の溶剤を除去
する医療用中空糸膜製造方法において、洗浄の工
程を多段に分割し、その洗浄水として、無菌水を
使用し、中空糸膜の走行する方向と逆方向に流下
させることを特徴とする医療用中空糸膜の製造方
法。
1. In a medical hollow fiber membrane manufacturing method in which a polymer compound is dissolved in a solvent to obtain a spinning solution, this spinning solution is extruded from a spinning nozzle together with a core liquid, solidified, and then washed to remove the solvent from the spinning solution. A method for manufacturing a medical hollow fiber membrane, characterized in that the process is divided into multiple stages, and sterile water is used as the washing water, and the water is allowed to flow down in a direction opposite to the direction in which the hollow fiber membrane runs.
JP24289183A 1983-12-22 1983-12-22 Production of medical hollow yarn mambrane Granted JPS60132566A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP24289183A JPS60132566A (en) 1983-12-22 1983-12-22 Production of medical hollow yarn mambrane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24289183A JPS60132566A (en) 1983-12-22 1983-12-22 Production of medical hollow yarn mambrane

Publications (2)

Publication Number Publication Date
JPS60132566A JPS60132566A (en) 1985-07-15
JPH0443690B2 true JPH0443690B2 (en) 1992-07-17

Family

ID=17095759

Family Applications (1)

Application Number Title Priority Date Filing Date
JP24289183A Granted JPS60132566A (en) 1983-12-22 1983-12-22 Production of medical hollow yarn mambrane

Country Status (1)

Country Link
JP (1) JPS60132566A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62117813A (en) * 1985-11-15 1987-05-29 Nikkiso Co Ltd Production of hollow fiber
JP4810757B2 (en) * 2001-06-05 2011-11-09 栗田工業株式会社 Ultrafiltration membrane for ultrapure water production and its pre-cleaning method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS536627A (en) * 1976-07-08 1978-01-21 Nippon Zeon Co Ltd Hollow fibers
JPS52148487A (en) * 1976-06-04 1977-12-09 Asahi Chem Ind Co Ltd Filter membrane of hollow fiber

Also Published As

Publication number Publication date
JPS60132566A (en) 1985-07-15

Similar Documents

Publication Publication Date Title
KR100432464B1 (en) Polysulfone Hollow Fiber Semipermeable Membrane
CN101703893B (en) Hollow fiber ultrafiltration composite membrane and preparation method and application thereof
JPH06165926A (en) Polysulfone-based hollow fiber membrane and method for producing the same
AU660425B2 (en) High efficiency removal of low density lipoprotein-cholesterol from whole blood
US7087168B2 (en) Hollow fiber membrane for purifying blood
WO1998052683A1 (en) Polysulfone-base hollow-fiber hemocathartic membrane and processes for the production thereof
JP3366040B2 (en) Polysulfone-based semipermeable membrane and method for producing the same
AU672856B2 (en) High flux hollow fiber membrane
JP2006198611A (en) Production method of separation membrane, and production method of separation membrane module using the separation membrane
JP3640737B2 (en) Polysulfone-based permselective hollow fiber membrane
GB2086798A (en) Microporous cellulose membrane
JP2020533166A (en) Microporous membrane and its manufacturing method
JPH0443690B2 (en)
JP3297707B2 (en) Modified hollow fiber and method for producing the same
JPH02167232A (en) Method for removing virus
JP2894133B2 (en) Hollow fiber and method for producing the same
JP2005137996A (en) Permselective separation membrane
CN1094380C (en) Material of artificial kidney for hemodialysis and its preparing process
JPH0970431A (en) Production of polysulfone hollow fiber type artificial kidney and artificial kidney
JPH0366380A (en) Hollow fiber type plasma separating membrane
JPH03228671A (en) Porous regenerated cellulose membrane for removing mycoplasma and removal of mycoplasma
JPH03196819A (en) Method for removing mycoplasma
JP2000325763A (en) Production of hollow-fiber membrane for hemocatheresis, and hollow-fiber membrane thereof
KR20050078748A (en) A blood compatible hollow fiber membrane, and a process of preparing for the same
JP2009078121A (en) Blood purifier and its production method